martes, 29 de noviembre de 2016

Lung Cancer Awareness Month 1 | National Guideline Clearinghouse 1

Search | National Guideline Clearinghouse
Lung Cancer Awareness Month 1 |  National Guideline Clearinghouse 1
ngc

Health Awareness Topics: November 2016

  • GUIDELINE SUMMARY
  •  
  • NGC:010540
  •  
  • 2013 AUG

EGFR-TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010035
  •  
  • 2013 APR 18

Screening high-risk populations for lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:009397
  •  
  • 2011 JUN

Non-small cell lung cancer stage I.

  • GUIDELINE SUMMARY
  •  
  • NGC:009227
  •  
  • 1995 (REVISED 2012)

ACR Appropriateness Criteria® radiographically detected solitary pulmonary nodule.

  • GUIDELINE SUMMARY
  •  
  • NGC:009682
  •  
  • 1996 (REVISED 2012)

ACR Appropriateness Criteria® nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.

  • GUIDELINE SUMMARY
  •  
  • NGC:010663
  •  
  • 2014

ACR Appropriateness Criteria® occupational lung diseases.

  • GUIDELINE SUMMARY
  •  
  • NGC:010163
  •  
  • 1995 (REVISED 2013)

ACR Appropriateness Criteria® non-invasive clinical staging of bronchogenic carcinoma.

  • GUIDELINE SUMMARY
  •  
  • NGC:009872
  •  
  • 2003 JAN (REVISED 2013 MAY)

Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  • GUIDELINE SUMMARY
  •  
  • NGC:009677
  •  
  • 1996 (REVISED 2012)

ACR Appropriateness Criteria® spinal bone metastases.

  • GUIDELINE SUMMARY
  •  
  • NGC:010348
  •  
  • 2014 APR

Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010391
  •  
  • 2012 MAY

Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.

No hay comentarios:

Publicar un comentario